BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32046108)

  • 1. Interleukin-27 Gene Delivery Targeting IL-6Rα-Expressing Cells as a Stress Response Therapy.
    Figueiredo Neto M; Liu S; Salameh JW; Yokota H; Figueiredo ML
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32046108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of interleukin-13 and interleukin-6 on Jak/STAT signaling and cell viability in pancreatic β-cells.
    Russell MA; Cooper AC; Dhayal S; Morgan NG
    Islets; 2013; 5(2):95-105. PubMed ID: 23510983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-6 and Interferon-α Signaling
    Danziger O; Pupko T; Bacharach E; Ehrlich M
    Front Immunol; 2018; 9():94. PubMed ID: 29441069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFN-γ-induced IL-27 and IL-27p28 expression are differentially regulated through JNK MAPK and PI3K pathways independent of Jak/STAT in human monocytic cells.
    Blahoianu MA; Rahimi AA; Kozlowski M; Angel JB; Kumar A
    Immunobiology; 2014 Jan; 219(1):1-8. PubMed ID: 23891538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble IL-6 Receptor and IL-27 Subunit p28 Protein Complex Mediate the Antiviral Response through the Type III IFN Pathway.
    Yang X; Hao H; Xia Z; Xu G; Cao Z; Chen X; Liu S; Zhu Y
    J Immunol; 2016 Sep; 197(6):2369-81. PubMed ID: 27527594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipocalin-2 regulates the expression of interferon-stimulated genes and the susceptibility of prostate cancer cells to oncolytic virus infection.
    Barer L; Schröder SK; Weiskirchen R; Bacharach E; Ehrlich M
    Eur J Cell Biol; 2023 Jun; 102(2):151328. PubMed ID: 37321037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human cytokines activate JAK-STAT signaling pathway in porcine ocular tissue.
    Fasler-Kan E; Barteneva NS; Ketterer S; Wunderlich K; Reschner A; Nurzhanova A; Flammer J; Huwyler J; Meyer P
    Xenotransplantation; 2013; 20(6):469-80. PubMed ID: 24289470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of JAK-STAT Signaling Activation in Hypertrophied Ligamentum Flavum.
    Delen E; Doğanlar O; Delen Ö; Doğanlar ZB; Kılınçer C
    World Neurosurg; 2020 May; 137():e506-e516. PubMed ID: 32059970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the IL-6R/Jak/stat pathway is associated with a poor outcome in resected pancreatic ductal adenocarcinoma.
    Denley SM; Jamieson NB; McCall P; Oien KA; Morton JP; Carter CR; Edwards J; McKay CJ
    J Gastrointest Surg; 2013 May; 17(5):887-98. PubMed ID: 23435739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-Mediated Targeting of Cytokine Interleukin-27 Enhances Its Bioactivity
    Figueiredo ML; Figueiredo Neto M; Salameh JW; Decker RE; Letteri R; Chan-Seng D; Emrick T
    Mol Ther Methods Clin Dev; 2020 Jun; 17():739-751. PubMed ID: 32346551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FPS-ZM1 inhibits LPS-induced microglial inflammation by suppressing JAK/STAT signaling pathway.
    Wang L; Zhao D; Wang H; Wang L; Liu X; Zhang H
    Int Immunopharmacol; 2021 Nov; 100():108117. PubMed ID: 34509933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-canonical Notch signaling activates IL-6/JAK/STAT signaling in breast tumor cells and is controlled by p53 and IKKα/IKKβ.
    Jin S; Mutvei AP; Chivukula IV; Andersson ER; Ramsköld D; Sandberg R; Lee KL; Kronqvist P; Mamaeva V; Ostling P; Mpindi JP; Kallioniemi O; Screpanti I; Poellinger L; Sahlgren C; Lendahl U
    Oncogene; 2013 Oct; 32(41):4892-902. PubMed ID: 23178494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Non-Receptor Protein Tyrosine Phosphatase PTPN6 Mediates a Positive Regulatory Approach From the Interferon Regulatory Factor to the JAK/STAT Pathway in
    Luo M; Xu X; Liu X; Shen W; Yang L; Zhu Z; Weng S; He J; Zuo H
    Front Immunol; 2022; 13():913955. PubMed ID: 35844582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of alpha subunit of eukaryotic translation initiation factor 2 (eIF2 alpha) phosphorylation by the human papillomavirus type 18 E6 oncoprotein: implications for eIF2 alpha-dependent gene expression and cell death.
    Kazemi S; Papadopoulou S; Li S; Su Q; Wang S; Yoshimura A; Matlashewski G; Dever TE; Koromilas AE
    Mol Cell Biol; 2004 Apr; 24(8):3415-29. PubMed ID: 15060162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JAK/STAT pathway plays a critical role in the proinflammatory gene expression and apoptosis of RAW264.7 cells induced by trichothecenes as DON and T-2 toxin.
    Wang X; Liu Q; Ihsan A; Huang L; Dai M; Hao H; Cheng G; Liu Z; Wang Y; Yuan Z
    Toxicol Sci; 2012 Jun; 127(2):412-24. PubMed ID: 22454431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of Tapasin-modified CTL epitope peptide via cytoplasmic transduction peptide induces CTLs by JAK/STAT signaling pathway in vivo.
    Wu S; Chen X; Tang Y; Zhang Y; Li D; Chen J; Wang J; Tang Z; Zang G; Yu Y
    Acta Biochim Biophys Sin (Shanghai); 2018 Feb; 50(2):181-190. PubMed ID: 29340620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of the interleukin-11 receptor and evidence of STAT3 activation in prostate carcinoma.
    Campbell CL; Jiang Z; Savarese DM; Savarese TM
    Am J Pathol; 2001 Jan; 158(1):25-32. PubMed ID: 11141475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LINC01116 targets miR-520a-3p and affects IL6R to promote the proliferation and migration of osteosarcoma cells through the Jak-stat signaling pathway.
    Zhang B; Yu L; Han N; Hu Z; Wang S; Ding L; Jiang J
    Biomed Pharmacother; 2018 Nov; 107():270-282. PubMed ID: 30098545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-27 gene delivery for modifying malignant interactions between prostate tumor and bone.
    Zolochevska O; Ellis J; Parelkar S; Chan-Seng D; Emrick T; Wei J; Patrikeev I; Motamedi M; Figueiredo ML
    Hum Gene Ther; 2013 Dec; 24(12):970-81. PubMed ID: 24028178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reengineering Tumor Microenvironment with Sequential Interleukin Delivery.
    Figueiredo ML; Letteri R; Chan-Seng D; Kumar S; Rivera-Cruz CM; Emrick TS
    Bioengineering (Basel); 2021 Jun; 8(7):. PubMed ID: 34209203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.